Multiple sclerosis
Study highlights its benefits to quality of life when compared with physical exercise
Her life's work has been to rid the world of MS and now Nancy Davis believes she’s getting ever closer. NR Times meets the tireless Race to Erase MS founder who has been the catalyst for 20+ FDA-approved MS therapies and US$50m in research funding.
A well-worn phrase from success coaching parlance says that the best way to take the island, is to ‘burn the boats’. Out of absolute necessity comes achievement – and after the point of no return, there is nothing to be done but move forward and get to it. That point for Nancy Davis came in 1991 when, at age 33, she was diagnosed with MS. Faced with a relative treatment black-out by today’s standards, and against the backdrop of an unhappy marriage, the fate of her three children as the disease progressed was necessity number one. Then there was the prospect of her own existence. A doctor said the best she could hope for was enough mobility function to operate a TV controller. And so sparked a race against time, not only to save herself, but to help others with MS avoid a similarly bleak outlook. Read on to find out how Nancy's journey since has helped to bring numerous new MS treatments to market and why she believes a cure for MS could be just five years away.
Epstein-Barr Virus found to be a leading cause of Multiple Sclerosis (MS)
First-of-its-kind research shows how a patient’s genetic makeup impacts neural cell functions
Study will look into existing drugs and how they could slow or stop disability worsening in people with MS
Specific toxin-producing gut bacteria found to play a key role in a new study
Study findings reveal impact of insomnia and sleep apnea on women with Multiple Sclerosis
Findings could help to influence dietary advice for young people at high risk of Multiple Sclerosis
New light has been shed on the long-term protective effect of pregnancy in women with Multiple Sclerosis (MS) through a new study. Research revealed how persistent differences in DNA methylation of genes related to neural plasticity was observed between women living with MS who have never been pregnant (nulligravida) and those who have given birth [...]
VIM Healthcare discuss its potential positive impact on those living with Multiple Sclerosis
